In 2016, media coverage of synthetic cannabinoid use and relevant hospitalizations engendered unconstructive hysteria. Stories around the drug’s presence in Brooklyn referred to people who use “K2” as zombies, and emphasized the spike in hospitalizations, all with minor dialogue in